Dr. Palmer is leading new studies to confirm fibrosis reversal results and explore combining leronlimab with other therapies, aiming to prepare for a potential Phase 2b or Phase 3 trial possibly?
(2)
(0)
CytoDyn Inc (CYDY) Stock Research Links
Federal Whistleblower
SEC Submission HL-1412396
DOJ Ref #20250705-0001